I now have comprehensive material. Here is a complete, well-illustrated answer:
Calcium Homeostasis
1. Body Calcium Distribution
An adult human body contains approximately 1000-1300 g of calcium, distributed as:
| Compartment | % of total |
|---|
| Bone and teeth (as hydroxyapatite) | 99.3% |
| Soft tissues (intracellular) | 0.6% |
| Extracellular fluid (incl. plasma) | 0.1% |
Intracellular free Ca²⁺ is maintained at a very low concentration (~100 nM / 0.1 µmol), creating a 10,000-fold gradient compared to extracellular Ca²⁺ (~1 mM). This gradient is physiologically critical.
- Brenner and Rector's The Kidney, p. 796
2. Plasma Calcium - Normal Values and Fractions
Normal total serum calcium: 8.6-10.3 mg/dL (2.15-2.57 mmol/L)
Calcium in blood exists in three fractions:
| Fraction | % | Notes |
|---|
| Protein-bound | 40% | 90% bound to albumin, 10% to globulins |
| Ionized (free) Ca²⁺ | 48% | Physiologically active; normal 4.65-5.28 mg/dL |
| Complexed (phosphate, citrate, lactate, bicarbonate) | 12% | Filterable but not active |
Ionized Ca²⁺ is the physiologically active form - it regulates CaSR signaling, cardiac contractility, neuromuscular activity, and bone mineralization.
Albumin Correction Formula
When albumin is low, total calcium falls but ionized calcium may be normal:
Adjusted Ca (mg/dL) = Measured Ca (mg/dL) + 0.8 × (4 - albumin [g/dL])
Important: Alkalosis decreases free Ca²⁺ (enhanced albumin binding); acidosis increases free Ca²⁺ (H⁺ displaces Ca²⁺ from albumin). A pH drop of 0.1 raises ionized Ca²⁺ by ~0.1 mEq/L.
- Brenner and Rector's The Kidney, pp. 796-797
3. The Three Organs and Three Hormones
Ca²⁺ homeostasis involves the coordinated interaction of three organ systems (intestine, kidney, bone) regulated by three hormones (PTH, Vitamin D, Calcitonin).
Fig. 9.35 - Costanzo Physiology: Ca²⁺ homeostasis in an adult eating 1000 mg/day elemental Ca²⁺
Daily Calcium Balance (in a person on 1000 mg/day)
- Ingested: 1000 mg/day
- GI absorption: 350 mg absorbed; 150 mg secreted back (salivary, pancreatic, intestinal fluids) → net absorption = 200 mg/day
- Fecal excretion: 800 mg/day
- Renal filtration: ~10 g/day filtered; ~200 mg excreted in urine (rest reabsorbed)
- Bone: 500 mg released (resorption) = 500 mg deposited (formation) → net zero in young adults
4. Parathyroid Hormone (PTH)
Structure
- 84-amino acid single-chain polypeptide
- Synthesized as preproPTH (115 aa) → signal peptide cleaved → proPTH (90 aa) → 6 more aa cleaved in Golgi → final PTH (84 aa)
- Biologic activity resides entirely in the N-terminal 34 amino acids
- Secreted by chief cells of the 4 parathyroid glands
Regulation of Secretion - Calcium-Sensing Receptor (CaSR)
The parathyroid cell membrane contains Ca²⁺-sensing receptors (CaSR) linked via Gq protein to phospholipase C:
- High extracellular Ca²⁺ → Ca²⁺ binds CaSR → activates phospholipase C → ↑ IP₃/Ca²⁺ → inhibits PTH secretion
- Low extracellular Ca²⁺ → decreased CaSR binding → stimulates PTH secretion (within seconds)
- PTH secretion is maximal when plasma Ca²⁺ falls to ~7.5 mg/dL
Other regulators of PTH secretion:
- Hypomagnesemia → stimulates PTH (but severe chronic hypomagnesemia, e.g. alcoholism, inhibits PTH synthesis and secretion)
- 1,25-dihydroxycholecalciferol → directly inhibits PTH synthesis and secretion
- Hyperphosphatemia and elevated FGF-23 → stimulate PTH
- Chronic hypocalcemia → secondary hyperparathyroidism (parathyroid hyperplasia, increased PTH synthesis over 24-48 hours)
Actions of PTH (all raise plasma Ca²⁺)
PTH receptor is coupled via Gs protein → adenylyl cyclase → ↑ cAMP → protein kinases
| Target | Action | Result |
|---|
| Bone | Indirect stimulation of osteoclasts via osteoblast-derived cytokines (RANKL) - receptors on osteoblasts, not osteoclasts | ↑ Bone resorption → releases Ca²⁺ and phosphate into ECF |
| Kidney - proximal tubule | Inhibits Na⁺-phosphate cotransport | ↓ Phosphate reabsorption → phosphaturia (clears phosphate that would otherwise complex ECF Ca²⁺) |
| Kidney - distal tubule | Stimulates Ca²⁺ reabsorption | ↑ Plasma Ca²⁺ |
| Kidney - proximal tubule | Activates renal 1α-hydroxylase | ↑ Conversion of 25-OH-D₃ → 1,25-(OH)₂-D₃ (active vitamin D) |
| Intestine | Indirect - via 1,25-(OH)₂-D₃ | ↑ Ca²⁺ absorption from gut |
Note: PTH phosphaturic action is critical - if phosphate released from bone were not cleared renally, it would complex with the released Ca²⁺ in ECF and blunt the rise in ionized Ca²⁺.
- Costanzo Physiology 7e, pp. 453-455
5. Vitamin D (Calcitriol)
Synthesis Pathway
- Skin: 7-dehydrocholesterol → cholecalciferol (UV light) OR from diet
- Liver: Cholecalciferol → 25-hydroxycholecalciferol (25-OH-D₃) - the main circulating form, bound to α-globulin; biologically inactive
- Kidney (mitochondrial 1α-hydroxylase):
- If Ca²⁺ deficient → 1,25-(OH)₂-D₃ (calcitriol) - the active form
- If Ca²⁺ sufficient → 24,25-(OH)₂-D₃ - inactive
1α-hydroxylase is activated by: ↓ plasma Ca²⁺, ↑ PTH, ↓ plasma phosphate
Actions of 1,25-(OH)₂-D₃ (Calcitriol)
Acts as a steroid hormone - stimulates gene transcription and new protein synthesis:
| Target | Action |
|---|
| Intestine (major site) | Induces synthesis of calbindin D-28K (Ca²⁺-binding protein) → ↑ Ca²⁺ and phosphate absorption |
| Kidney | ↑ Ca²⁺ reabsorption AND ↑ phosphate reabsorption (unlike PTH which causes phosphaturia) |
| Bone | Acts synergistically with PTH → stimulates osteoclast activity → bone resorption to supply Ca²⁺/PO₄ for new bone mineralization |
Overall goal: raise Ca²⁺ × phosphate product to promote bone mineralization.
Intestinal Mechanism (Calbindin D-28K)
- Ca²⁺ diffuses across luminal membrane down electrochemical gradient
- Binds intracellularly to calbindin D-28K (a cytosolic shuttle/buffer)
- Ca²⁺-ATPase pumps Ca²⁺ across basolateral membrane into blood
6. Calcitonin
- Secreted by parafollicular C cells of the thyroid
- Released in response to hypercalcemia
- Inhibits osteoclast activity → ↓ bone resorption → ↓ plasma Ca²⁺
- Less potent than PTH in day-to-day calcium regulation; more important during growth, pregnancy, and lactation
- Clinically used pharmacologically in Paget's disease and hypercalcemia
7. Summary: Response to Hypocalcemia
↓ Plasma Ca²⁺
↓
↑ PTH secretion (within seconds via CaSR)
├── Bone: ↑ osteoclast resorption → Ca²⁺ + PO₄ released
├── Kidney proximal: ↑ 1α-hydroxylase → ↑ active Vitamin D
├── Kidney proximal: ↓ phosphate reabsorption (phosphaturia) → prevents Ca-PO₄ complexing
├── Kidney distal: ↑ Ca²⁺ reabsorption
└── Intestine (via Vitamin D): ↑ Ca²⁺ absorption (calbindin D-28K)
↓
↑ Plasma Ca²⁺ → normal → inhibits PTH (negative feedback)
8. Clinical Disorders of Calcium Homeostasis
| Disorder | Key Mechanism |
|---|
| Hypercalcemia | Most commonly: ↑ osteoclastic bone resorption (primary hyperparathyroidism, malignancy via PTHrP) |
| Hypocalcemia | Hypoparathyroidism, vitamin D deficiency, hypomagnesemia, CKD |
| Rickets (children) | Vitamin D deficiency → insufficient Ca²⁺/PO₄ for growing bone mineralization |
| Osteomalacia (adults) | Vitamin D deficiency → softening of weight-bearing bones |
| Secondary hyperparathyroidism | Chronic hypocalcemia/renal disease → parathyroid hyperplasia, ↑↑ PTH |
| Cell injury (intracellular Ca²⁺) | Ischemia/toxins → excessive cytosolic Ca²⁺ → activates phospholipases, proteases, endonucleases, ATPases → cell death |
- Costanzo Physiology 7e; Brenner and Rector's The Kidney; Robbins & Cotran Pathologic Basis of Disease